Money

Calif talks about the EUA process, the science and who should make the final call.

The U.S. Food and Drug Administration (FDA) is reviewing two emergency use authorization requests for COVID-19 vaccines, with an outside advisory committee scheduled to meet next Thursday to review data from Pfizer and its German partner BioNTech.
Axios Re:Cap digs in with former FDA commissioner Rob Calif about the EUA process, the science and who should make the final call.